Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006035
Filing Date
2025-02-28
Accepted
2025-02-28 17:15:11
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 form4-02282025_050206.html 4  
1 form4-02282025_050206.xml 4 3359
  Complete submission text file 0001415889-25-006035.txt   4804
Mailing Address C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025
Business Address
Horan Christopher (Reporting) CIK: 0001736819 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42179 | Film No.: 25692164

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

EIN.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)